PROPEL® Sinus Stent
Treat Inflammation Where It Happens
Minimally invasive sinusitis surgery is one of the most effective treatments for chronic sinusitis because the diseased or obstructive tissue is removed from the sinuses. But given the chronic nature of the condition, ongoing inflammation and scarring can threaten to block sinuses again. PROPEL can help decrease inflammation for longer-term relief.1
Ultimately, patients want to know
“ How can I
find relief? “
PROPEL SINUS STENT
The PROPEL technology represents a medical breakthrough. It has been proven to improve the outcomes of surgery by minimizing post-operative inflammation.1
PROPEL Sinus Stent Is Clinically Proven To1:
Keep the sinuses open after surgery.
Precisely deliver medication directly into the healing tissues.
Dissolve on its own so removal is not required.
You want to experience as much relief from chronic sinusitis as possible—for as long as possible. Sinus surgery with the PROPEL sinus stent uses a clever combination of device design and medication delivery to improve the outcomes of surgery and provide relief at the source.
How PROPEL Sinus Stent Works
PROPEL is a small, innovative, stent-like device. It props open the sinus after surgery. This allows air to circulate and mucus to drain, so proper sinus functioning and healing can take place.– +
PROPEL sinus stent contains an anti-inflammatory medication. It delivers the drug in a controlled manner, directly into the healing sinus tissues that need it. This helps to decrease inflammation (swelling), and prevent scarring.1– +
As PROPEL sinus stent delivers the medication, it slowly dissolves. This takes about 30 to 45 days. It can be left to dissolve or be removed at any time.– +
PROPEL sinus stent is clinically proven to maintain the outcomes of surgery.1 This means less likelihood for additional surgical interventions or the need for oral steroids.1– +
PROPEL sinus stent is lightweight, and usually cannot be felt once in place. And, its unique dissolvable design eliminates the need for removal, for additional peace of mind.– +
PROPEL Sinus Stent Outcomes
Dissolves over approximately 30–45 days.
Reducing the need for additional post-surgery interventions and oral steroid medications by 35%.1
Reducing polyp formation (harmless non-cancerous growths) by 46%.1
Why find an ENT physician ?
If you suffer from chronic sinus infections, you may need to see an ENT physician, who is also called an ear, nose, and throat doctor or an otolaryngologist. These specialized physicians are experts in both the medical and surgical management of chronic sinusitis.
Intersect ENT makes information available about physicians and facilities that offer the PROPEL® mometasone furoate sinus implant. Physicians and facilities are listed based upon proximity to the zip code you have entered.
Learn More About Sinusitis
Sinusitis is a complex and frustrating disease. But learning about the causes, symptoms and treatments available can help you find the solution that is best for you.
December 05th, 2017
Breathing is fundamental and usually automatic. If you’re doing it right, you don’t notice it. If your breathing goes wrong,
November 24th, 2017
When sinus conditions occur, there are different topical treatments, or therapies that can be applied directly to the affected area
1. Forwith K et al. Laryngoscope. 2011;121:2473-2480. Based on SNOT-22 and RSDI patient-reported outcomes compared to baseline.
The purpose of the site is to help create awareness about sinusitis and treatment options for the disease. Please note that information contained on this site is not medical advice. It should not be used as a substitute for speaking with your physician. Always talk with your physician about diagnosis and treatment information.
The PROPEL sinus implants are intended for use after sinus surgery to maintain patency and to locally deliver steroids to the sinus mucosa: PROPEL for use in the ethmoid sinus, PROPEL Mini for use in the ethmoid sinus and frontal sinus opening, and PROPEL Contour for use in the frontal and maxillary sinus ostia. The implants are intended for use in patients ≥18 years of age. Contraindications include patients with intolerance to mometasone furoate (MF) or a hypersensitivity to bioabsorbable polymers. Safety and effectiveness of the implants in pregnant or nursing females have not been studied. Risks may include, but are not limited to, pain/pressure, displacement of implant, possible side effects of intranasal MF, sinusitis, epistaxis, and infection. For complete prescribing information see IFU at www.IntersectENT.com. Rx only.